Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02711709 · ClinicalTrials.gov registry record
Persistent Inflammation, Immunosuppression and Catabolism Syndrome (PICS): A New Horizon for Surgical Critical Care and Induced Frailty
A clinical trial of Sepsis, sponsored by University of Florida.
- Active
- Registry status
- 53
- Enrollment target
- 1
- Study location
NCT02711709 is a study of Sepsis that is active but no longer recruiting, run by University of Florida. The registered enrollment target is 53 participants, below the 6,564-participant average among 90 other Sepsis trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02711709, a study of Sepsis, is active but no longer recruiting, sponsored by University of Florida.
- ACTIVE NOT RECRUITING
- Registry status
- 53 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to define the natural history and causes of chronic critical illness (CCI) in surgical intensive care patients who have had sepsis. The investigator wants to study a sub-population of sepsis patients that have intra-abdominal sepsis. The purpose of this research study is to define the acute changes in frailty (weakness, slowness, loss of muscle mass), comorbidity (medical problems) and disability (difficulty with mobility and performing routine daily functions) after having an infection that is located in the abdominal cavity or torso. The investigator believes having severe infection contributes to acute and permanent changes in these areas, especially in those of advanced age.
Conditions Studied
Interventions
- OTHER Frailty Measurements
- OTHER Modified Minnesota Leisure Time Activities
- OTHER Computed tomography morphometrics
- OTHER Mobility Monitors
Study Locations (1)
Florida
- UF Health at Shands hospital - Gainesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 53 participants |
| Start Date | 2016-04 |
| Est. Completion | 2025-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02711709
The ClinicalTrials.gov registry entry for NCT02711709 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 53 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 6,564-participant average among 90 other Sepsis trials with a reported enrollment target (99% lower). The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Sepsis appearing as the primary indexed condition, and to 4 interventions - of which Frailty Measurements is the first listed.
NCT02711709 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT02711709 about?
NCT02711709 is a clinical study titled "Persistent Inflammation, Immunosuppression and Catabolism Syndrome (PICS): A New Horizon for Surgical Critical Care and Induced Frailty". The purpose of this study is to define the natural history and causes of chronic critical illness (CCI) in surgical intensive care patients who have had sepsis. The investigator wants to study a sub-population of sepsis patients that have intra-abdominal sepsis. The purpose of this research study is...
What is the current status of trial NCT02711709?
This trial is currently active not recruiting. The enrollment target is 53 participants. The study started on 2016-04. Estimated completion is 2025-12-31.
What conditions does trial NCT02711709 study?
This clinical trial studies the following conditions: Sepsis.
What interventions are being tested in trial NCT02711709?
The interventions under investigation include: Frailty Measurements (OTHER), Modified Minnesota Leisure Time Activities (OTHER), Computed tomography morphometrics (OTHER), Mobility Monitors (OTHER).
Who is sponsoring clinical trial NCT02711709?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02711709 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sepsis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The APS Phenotyping Study
RECRUITING
-
Senolytics To slOw Progression of Sepsis (STOP-Sepsis) Trial
RECRUITING · Phase 2
-
Early Versus Late Adjunctive Vasopressin in Septic Shock
RECRUITING · Phase 4
-
Renin Angiotensin Aldosterone System In Septic Kids
RECRUITING
-
The RightCall: Implementing a Sepsis Diagnostic Toolkit to Improve Pediatric Diagnosis in ED Transfer Calls
RECRUITING · NA
-
External Drainage of Thoracic Duct Lymph to Reduce Inflammatory Cytokines in Septic Shock Patients
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.